The PALB2 gene helps your cells repair damaged DNA, working closely with the BRCA1 and BRCA2 genes to keep cell growth more controlled. If it does not work properly, DNA damage can build up, which can raise the chance of breast cancer and some other cancers, including pancreatic cancer. People born with nonworking copies of both copies of the PALB2 gene can develop Fanconi anemia, a childhood condition that affects blood cells and growth. PALB2 became better known as hereditary cancer testing expanded beyond BRCA1 and BRCA2.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or managing processes in the body. Some genes carry the directions needed to produce proteins, which do the work inside cells. Other genes are used mainly to regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
PALB2Gene function
What if the gene works
The PALB2 gene helps cells repair damaged DNA, especially harmful double strand breaks. By working with BRCA proteins, it supports healthy cell growth and helps keep genetic information stable.
Risk
What if the gene does not work
Some variants in the PALB2 gene raise the chance of breast cancer and, to a lesser extent, pancreatic or ovarian cancer. More disruptive variants can be linked to earlier or higher risk. When both copies are severely affected, children can develop Fanconi anemia.
Treatment
What does that mean for your treatment
At present, a pathogenic variant in the PALB2 gene has clear treatment relevance mainly in advanced prostate cancer, where it can support use of PARP inhibitors such as olaparib. In other PALB2 related cancers, PARP inhibitors and platinum chemotherapy are under active study and may be considered case by case.
Conditions associated with PALB2
Gene function
What if the gene works
Every day, your cells need to copy and repair DNA with care. The PALB2 gene supports these routine jobs by helping repair teams find the right place and work together. Knowing what the PALB2 gene does in your cells helps explain how your body keeps its genetic instructions stable over time.
When DNA strands break, the PALB2 gene helps your cells rebuild the damage using the matching DNA copy as a guide. This supports accurate repair and helps keep genetic instructions stable.
PALB2 acts like a connector that brings key repair proteins, including BRCA1 and BRCA2, into the same working group. This helps the repair process start in the right place and stay organized.
While cells prepare to divide, PALB2 helps protect DNA as it is being copied. This supports smoother copying and lowers the chance of DNA damage building up during normal cell growth.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How PALB2 gene variants affect DNA repair varies with the exact change. More severe variants can shorten the PALB2 protein, make it unstable, or disrupt its link with BRCA2, so damaged DNA is repaired less reliably. Milder variants may only partly reduce this repair activity. This spectrum can shape cancer risk, and severe variants in both gene copies can cause Fanconi anemia, which often appears earlier in life.
How variants are linked to conditions
Pathogenic variants in the PALB2 gene are best known for raising the chance of breast cancer and are also linked to higher risks of pancreatic and ovarian cancer. This is why PALB2 gene breast cancer risk is often discussed in hereditary cancer testing, although carrying a variant does not mean cancer will definitely develop. When a child inherits pathogenic PALB2 variants in both copies of the gene, this can cause a rare condition called Fanconi anemia.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most have no direct impact on health and instead reflect natural human diversity. For many genes, carrying a variant connected with a condition suggests a possible association, not a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
With a harmful PALB2 variant, much of the risk is already set by the gene itself, especially for breast cancer, so lifestyle changes are not known to remove that risk. Risk can still vary with age, family history, and the type of cancer involved, and smoking may further raise pancreatic cancer risk.
Inheritance of PALB2 variants
How PALB2 gene variants are inherited depends on the condition involved. For the inherited cancer risk linked to one harmful PALB2 variant, the pattern is autosomal dominant, so a parent carrying the variant can pass it to each child with a 50% chance. Some people have a new variant that was not inherited from either parent. When a child inherits harmful PALB2 variants from both parents, this follows an autosomal recessive pattern and is linked to a rare Fanconi anemia condition.
What does my PALB2 result mean for my family?
For families with a harmful PALB2 change linked to higher cancer risk, close relatives can sometimes carry the same change, so the result may matter for parents, brothers, sisters, and children. PALB2 can also be linked to a separate rare childhood condition when a child inherits two changed copies, so family meaning can differ depending on which PALB2-related condition is involved. In some families, a PALB2 change starts new in one person rather than being passed down from a parent.
Genetic information
Genetic testing
How you find out about variants
PALB2 genetic testing for inherited cancer risk can show whether you carry a variant linked to a higher chance of certain cancers. It usually uses a blood or saliva sample, and a lab reads the PALB2 gene for DNA changes. Results may be reported as positive, negative, or uncertain.
When should I consider getting a genetic test?
Consider PALB2 testing if you or close relatives have had breast cancer at a young age, male breast cancer, pancreatic cancer, or several family members with these cancers. Testing can also help explain a strong family history of hereditary cancer and guide screening for relatives.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it can explain varies depending on the condition and the type of variant involved. Factors such as lifestyle, environment, age, and medical history also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug faster, while another may process it more slowly or be more sensitive to its effects. These differences are common and can influence how well a treatment works or the chance of side effects. Medication response also depends on other factors, including age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It studies gene-drug relationships to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how the body handles a drug or how strong its effects are. This information can support more informed and individualized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the PALB2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication use, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor. If you already know you have a PALB2 change and are making cancer treatment decisions, mention it to your oncology team, because PALB2 is being studied as a marker of response to PARP inhibitors and platinum-based chemotherapy.
History
PALB2 entered cancer genetics in 2006, when researchers identified it as a key partner of the BRCA2 pathway and gave it the name “partner and localizer of BRCA2.” Soon after, inherited variants in the PALB2 gene were linked to a form of Fanconi anemia, which helped show that the gene mattered in both rare inherited conditions and cancer biology. From these first observations, research expanded steadily. By 2014, larger family studies had confirmed that some pathogenic variants in the PALB2 gene are associated with a substantially increased risk of breast cancer. As genetic testing became more common, PALB2 moved from a lesser-known finding to a gene regularly included on hereditary cancer panels. Its history reflects how quickly a newly identified cancer gene can become important in everyday clinical care.